Company intelligence / Profile preview

SeaWith

Gwangmyeong, Gyeonggi-do, South Koreaseawith.net ↗

Ownership: Private
Development stage: Other

Overview

SeaWith has developed a proprietary process to produce cell-cultured beef using microalgae-derived growth media and seaweed scaffolds, significantly reducing reliance on animal-derived supplements like fetal bovine serum. Their flagship product, Welldone™, is positioned as a sustainable, cost-effective alternative to conventional beef. The company aims to bring its products to market by 2025 and has formed key partnerships to accelerate commercialization.

Modalities: Cultivated meat (cell-cultured meat)Cell culture technologyMicroalgae-based growth mediaSeaweed-based scaffolding
Industry: Non-Drug Biotech

Partnerships

Esco Aster (biomanufacturing partnership for scaling cultivated meat production)ORF Genetics (partnership for plant-based recombinant growth factors)

Beyond the preview

Go deeper on SeaWith.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SeaWith.

Explore the full profile